← Back
$IRWD All transactions

IRONWOOD PHARMACEUTICALS INC

A

$ Value

$0

Shares

45,000

Price

$0

Filed

Jun 12

Insider

Name

Dreyfus Andrew

Title

CIK

0001670893

Roles

Director

Transaction Details

Transaction Date

2025-06-10

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

228,313

Footnotes

The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year. | Since the date of the reporting person's last ownership report, the individual transferred 4,917 shares of Class A common stock to the individual's ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by the individual's ex-spouse.

Filing Info

Accession No.

0000950170-25-085437

Form Type

4

Issuer CIK

0001446847

Dreyfus Andrew's History

Date Ticker Type Value
2025-06-10 IRWD A $0
2025-05-13 ANRO A $0

Other Insiders at IRWD (90d)

Insider Bought Sold Last
DENNER ALEXANDER J $20.5M 2026-03-17
MCCOURT Thomas A
Chief Executive Officer
$740K 2026-03-10
Shetzline Michael
SVP, CMO, Head-Res&Drug
$122K 2026-03-10
Silver Ronald
Principal Accounting Officer
$90K 2026-03-10
John Minardo
Chief Legal Officer
$136K 2026-03-10
Martini Gregory S.
Chief Financial Officer
$82K 2026-03-10
Gaskins Tammi L
Chief Commercial Officer
$80K 2026-03-10